Connect with us
best Paper Writing service
mavi serum sipariş cialis sipariş hattı viagra siparişi pay vega 100 satın al


CVS Pharmacy announced it will start selling CBD-infused products in 8 states


CVS Pharmacy, a health care company announced this Wednesday that it will begin selling hemp-derived CBD based products in eight states entailing Alabama, Kentucky, Maryland, California, Colorado, Indiana, Illinois and Tennessee.It is a national drug store chain that plans to market topical cannabidiol products including creams, sprays and roll-ons as an “alternative source to relief”.

Proper verified checks will be carried out on all the products, assured CVS as it declares its partnership with a company that will be responsible for the testing of the products. Eurofins, a third party laboratory will be checking all the products for THC and CBD concentration and other contaminants as well, ensuring its safety for the consumers.

CVS claims that it will be working only with CBD product manufactures that are complying with the applicable laws. Only those products which will pass these independent tests will be introduced in the market to consumers.

Mike DeAngelis, CVS Health Spokesperson said, “We are carrying hemp-derived CBD products in select states to help meet consumer demand for alternative care options”.

CBD legalization came into effect after the discovery of its potential health benefits, especially to relieve pain, anxiety, stress and many other diseases. It has opened up new and much wider ways for treatment of patients that suffer from ailments.

CBD is basically a part of the hemp plant, which falls into the cannabis genus. Both, hemp and cannabis plants contain CBD, however Cannabis plants contain high levels of THC, a psychoactive component that can aggravate conditions like stress, anxiety, insomnia, depression, hallucinations and lead to permanent mental disorders.

Extensive research has proven that CBD can also render its effectiveness in cancer treatment. Although studies are still being continued and made by the FDA to approve CBD infused products, a number of companies have jumped on the opportunity to create products for capturing the market by its hook.

Dr. Margaret Haney, a professor of neurobiology at Columbia University Medical Center and director of Columbia’s Marijuana Research Laboratory says, “Societies have jumped far ahead of science. So, it’s showing up in lotions and pretty much any form of product one can use. There’s a lot of different ways one could use CBD, but the ways we have studied CBD is much more limited.”

CVS is rolling out its CBD based products in 800 stores present in over 8 states. The health care chain has almost 9,800 stores nationwide but however plans to start small. CVS says that the effectiveness of the products will vary from one product to another and from one patient to another and that they do not wish to market any of the items as a “cure-all” product.

“We’re going to walk slowly, but this is something we think our customers will be looking for,” CVS Health CEO Larry Merlo said in an interview Wednesday with CNBC’s Jim Cramer.

CVS made it quite clear that it will be following the rules issued by the FDA under which it is illegal to introduce drugs like CBD into the food supply or to the market as dietary supplements. Thus the company will not be selling any CBD-based supplements or food additives.

5,000+ people are already enjoying Exclusive CBD Deals in their InboxSign Up now to receive upto 50% off

“Selling unapproved products with unsubstantiated therapeutic claims is not only a violation of the law, but also can put patients at risk, as these products have not been proven to be safe or effective,” FDA Commissioner Scott Gottlieb said in a statement in December.

Ivan writes about Cannabis at The Cannabis Radar. He has a degree in Nutrition Sciences from University of Oklahoma Health Sciences Centre. He likes to spend his spare time reading to his daughter or spending time with his wife.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *